FIB-4 Liver Fibrosis Calculator
What this calculator tells you
The FIB-4 index is a screening score that combines age with three common lab values—AST, ALT, and platelet count—to estimate how likely advanced liver fibrosis may be. Fibrosis is the buildup of scar tissue after ongoing liver injury. It can happen in chronic viral hepatitis, alcohol-related liver disease, metabolic dysfunction-associated steatotic liver disease, autoimmune liver disease, and a range of other long-running conditions. Because fibrosis can progress quietly for years, clinicians often use simple noninvasive tools like FIB-4 to decide who appears low risk and who may benefit from a closer look.
This page is meant to explain the score in plain language while keeping the calculator fast to use. It does not diagnose cirrhosis, and it does not replace a clinical assessment. What it does well is organize familiar lab results into one structured number. In everyday practice that can help separate clearly reassuring patterns from patterns that deserve follow-up with elastography, repeat blood work, imaging, or specialist review.
For the most reliable result, enter one set of values from the same blood draw whenever possible. Age should be entered in years. AST and ALT should be entered in units per liter, usually written as U/L. Platelets should be entered in the standard count format used on most reports, usually shown as a number such as 160 or 220 with a unit of ×109/L. Mixing dates or mixing unit systems can make the score look more meaningful than it really is.
Each input contributes a different clue. Age increases the score because the same lab pattern tends to carry more concern in older adults. AST rises when liver cells are injured, although it can also rise with muscle injury or alcohol-related disease. ALT is more liver-focused, but it also changes in response to inflammation and fatty liver disease. Platelet count behaves differently: lower platelets can be an indirect clue that chronic scarring and portal pressure changes are becoming more significant.
That balance is why FIB-4 is most useful as a screening tool rather than a stand-alone answer. A temporarily high AST after strenuous exercise or acute illness can shift the score upward. A low platelet count from a non-liver cause can do the same. On the other hand, stable labs over time can make the trend much more informative than any single isolated number. When people understand that the score is part of a larger clinical story, they usually interpret it more safely and more accurately.
If you are using this tool for yourself, think of it as a quick summary rather than a verdict. A low score can be reassuring, but it is still worth matching that number to your diagnosis, symptoms, physical findings, and other tests. A high score can be important, but it still needs explanation. Good medical decisions come from the pattern as a whole, not from one calculator alone.
Formula, units, and age-adjusted cutoffs
The calculator uses the standard FIB-4 equation below. Higher age and higher AST increase the numerator, which tends to raise the result. Higher platelets and a higher square root of ALT increase the denominator, which tends to lower the result. Using the square root of ALT softens the effect of very large ALT spikes so that a short-term inflammatory flare does not overwhelm the calculation as much as a simple direct ALT term would.
In plain language, the score rises most readily when age and AST are relatively high and platelet count is relatively low. That pattern can be seen in advanced fibrosis, but it can also appear for other reasons, which is why interpretation matters just as much as arithmetic. The units expected here are the conventional ones used in most adult clinical practice:
- Age: years
- AST: aspartate aminotransferase in U/L
- ALT: alanine aminotransferase in U/L
- Platelets: platelet count in 109/L
Once the number is calculated, it is sorted using age-adjusted thresholds. Through age 65, the usual adult cutoffs are applied. Over age 65, higher cutoffs are used to reduce false positives, because aging alone can push the score upward even when fibrosis is not advanced. The table below shows the ranges used by this page.
| Age Group | FIB-4 Score Range | Fibrosis Risk Category |
|---|---|---|
| 65 years or younger | < 1.45 | Low risk |
| 65 years or younger | 1.45 – 3.25 | Indeterminate risk |
| 65 years or younger | > 3.25 | High risk |
| Over 65 years | < 2.0 | Low risk |
| Over 65 years | 2.0 – 2.67 | Indeterminate risk |
| Over 65 years | > 2.67 | High risk |
A low result generally suggests a lower likelihood of advanced fibrosis. An indeterminate result means the score does not clearly separate low risk from high risk, so another noninvasive test may be sensible. A high result raises concern for advanced fibrosis or cirrhosis and deserves prompt clinical review, especially if symptoms, imaging findings, or other laboratory abnormalities point in the same direction.
These categories are useful because they mirror how the score is used in practice: as an early sorting step. The strongest use case is not proving a diagnosis; it is identifying which people seem safely low risk and which people need a more precise next test. That is why the interpretation text shown after calculation is intentionally brief and practical.
Worked example and how to read the result
Suppose a 40-year-old patient has AST 90 U/L, ALT 60 U/L, and platelets 160 × 109/L. Using the formula gives the following calculation.
Because this patient is 65 or younger, the standard adult cutoffs apply. A result of 2.9 falls between 1.45 and 3.25, so it lands in the indeterminate range. That does not confirm severe fibrosis. It means the score is not reassuring enough to stop thinking, but it is not high enough to stand on its own as proof of advanced scarring either. In real practice, this is exactly the kind of result that often leads to repeat labs, elastography, or broader liver evaluation.
The short interpretation text below the calculator is designed to help at a glance, but it should be read with a few common-sense checks. First, confirm that the values were typed correctly and in the proper units. Second, ask whether anything temporary could have shifted AST or ALT, such as recent infection, heavy alcohol exposure, a medication change, a hospitalization, or unusually strenuous exercise. Third, consider whether a non-liver reason for low platelets could be affecting the denominator. Those simple questions can prevent overreaction to a number that looks more dramatic than the clinical picture really is.
The comparison table also shows why the same score can mean different things at different ages. This point is easy to miss when people copy a formula from another site without reading the interpretation rules. The math gives one continuous value, but the clinical meaning depends on which cutoff set applies to the person being assessed.
| Age | FIB-4 score | Risk category |
|---|---|---|
| 50 | 1.8 | Indeterminate |
| 50 | 3.4 | High |
| 70 | 1.8 | Low |
| 70 | 2.6 | Indeterminate |
If your result sits close to a cutoff, avoid reading too much into tiny differences. A score of 1.44 and a score of 1.46 can land on opposite sides of a threshold, yet the medical reality may be nearly the same. Borderline results are best handled by looking at the overall pattern, the reason for testing, and whether a second-line fibrosis test is available. This is one of the main reasons FIB-4 works well as a triage tool: it is strongest at separating clearly low-risk cases from clearly concerning ones, while the middle zone naturally calls for more context.
It is also worth remembering that different laboratories may use slightly different assay methods and reference ranges even when they report the same units. The formula itself uses the raw values, not the lab's normal range, but comparing scores over time is still cleaner when the testing environment is consistent. That practical detail matters more than many people expect.
Assumptions, limitations, and follow-up
Like any clinical score, FIB-4 assumes the inputs are accurate and relevant. It was built for risk estimation in chronic liver disease settings, not as a universal answer for every situation. Accuracy can be lower when enzyme elevations are driven by short-term illness, when platelet count is affected by hematologic conditions, or when lab values are not collected under comparable circumstances. That does not make the score useless; it simply defines the situations where extra caution is wise.
- The score estimates risk; it does not stage fibrosis with certainty.
- Acute illness, recent alcohol exposure, medications, muscle injury, or vigorous exercise can temporarily change AST or ALT.
- Platelet count can be low for reasons unrelated to liver scarring, including blood disorders and some treatments.
- Values are most meaningful when they come from the same blood draw and are entered in standard units.
- This calculator applies older-adult thresholds only when age is above 65, matching the rule used in the page script.
- Imaging, elastography, and sometimes biopsy may still be needed when the overall picture is unclear.
Follow-up depends on the result and on the person being evaluated. A low score is often reassuring enough for routine monitoring when the rest of the picture is calm. An indeterminate score often leads to a more specific noninvasive test. A high score is more urgent because it can reflect advanced fibrosis or cirrhosis, but even then the next step is usually confirmation and explanation rather than automatic labeling. Imaging, elastography, repeat labs, and sometimes referral to hepatology help answer the question that FIB-4 raises.
Trends also matter. If a score has been rising over several measurements, that pattern can be more informative than any single time point. The reverse is also true: improvement in weight, alcohol intake, diabetes management, antiviral treatment adherence, or overall liver inflammation can sometimes lower follow-up scores. A lower score, however, does not always mean scar tissue has fully reversed, just as a higher score does not by itself identify the cause of worsening. The calculator is best used as a structured marker of direction and level of concern.
When you repeat the test, try to compare like with like. Using the same lab system, similar timing, and a period when you are clinically stable improves the usefulness of the comparison. If one result looks very different from the rest of the pattern, confirmation may be more helpful than immediate conclusions. That steady, practical approach is usually safer than reacting to a single number in isolation.
Lifestyle and treatment decisions can also change how the result should be viewed. Better metabolic control, weight loss when appropriate, antiviral therapy, and reduced alcohol exposure may all improve the underlying situation even before a long-term structural answer is clear. FIB-4 is good at signaling whether the overall pattern is moving in a more or less concerning direction, but it is still only one part of follow-up care.
Common questions
Can I use this calculator without a doctor’s input? Yes, you can use it to understand the formula and estimate a score, but it should not replace medical advice. The safest approach is to treat the result as a starting point for discussion, especially if it is indeterminate or high.
What units should I use for the lab values? Enter age in years, AST and ALT in U/L, and platelet count in 109/L exactly as reported when possible. If your report formats platelets differently, convert carefully before calculating.
How often should I repeat the FIB-4 test? The right interval depends on the underlying liver condition and the purpose of monitoring. Some people only recalculate when new blood work is done, while others in active follow-up review it every 6 to 12 months or whenever treatment, symptoms, or risk factors change.
What should I do if my score is high? A high score should prompt medical review rather than self-diagnosis. Your clinician may consider repeat labs, transient elastography, imaging, or referral to a liver specialist to clarify whether advanced fibrosis is present.
Can lifestyle changes affect my FIB-4 score? They can. Lower alcohol exposure, better metabolic health, weight reduction when appropriate, and good control of the underlying liver condition may improve liver enzyme patterns over time. Still, the number should be interpreted in context rather than as a direct measure of scar tissue reversal.
Why are the cutoffs different after age 65? Age itself can raise the score even when fibrosis is not advanced. Using higher cutoffs in older adults helps reduce false positives and makes the tool more clinically sensible for that group.
Summary
The FIB-4 Liver Fibrosis Calculator is most helpful when it is used the way clinicians use it: as a quick screening step built from routine data, not as a final diagnosis. Enter the right units, rely on one blood draw when possible, read the result with the correct age-adjusted threshold, and interpret the number alongside history, symptoms, and follow-up testing. Used that way, the score becomes a practical guide for deciding whether simple monitoring is enough or whether a more detailed liver assessment deserves priority.
Optional Mini-Game: Formula Gate
If you want a quick, visual way to remember the formula, try this short arcade-style challenge. It does not affect your calculator result. In the game, Age and AST belong in the numerator, so they push FIB-4 upward. Platelets and √ALT belong in the denominator, so they help keep the score from climbing as quickly. Rotate the dual gate, route each lab token to the correct side, and keep the equation stable for the full run.
Educational takeaway: the real FIB-4 score rises when the numerator pressure from age and AST becomes larger relative to the denominator support from platelets and the square root of ALT.